Comprehensive Evaluation of TFF3 Promoter Hypomethylation and Molecular Biomarker Potential for Prostate Cancer Diagnosis and Prognosis
出版年份 2017 全文链接
标题
Comprehensive Evaluation of TFF3 Promoter Hypomethylation and Molecular Biomarker Potential for Prostate Cancer Diagnosis and Prognosis
作者
关键词
-
出版物
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
Volume 18, Issue 9, Pages 2017
出版商
MDPI AG
发表日期
2017-09-20
DOI
10.3390/ijms18092017
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- EAU-ESTRO-SIOG Guidelines on Prostate Cancer. Part 1: Screening, Diagnosis, and Local Treatment with Curative Intent
- (2017) Nicolas Mottet et al. EUROPEAN UROLOGY
- Heterogeneous patterns of DNA methylation-based field effects in histologically normal prostate tissue from cancer patients
- (2017) Mia Møller et al. Scientific Reports
- NCCN Guidelines Insights: Prostate Cancer Early Detection, Version 2.2016
- (2016) Peter R. Carroll et al. Journal of the National Comprehensive Cancer Network
- Large-scale evaluation of SLC18A2 in prostate cancer reveals diagnostic and prognostic biomarker potential at three molecular levels
- (2016) Christa Haldrup et al. Molecular Oncology
- Clinical and Emergent Biomarkers and Their Relationship to the Prognosis of Ovarian Cancer
- (2016) Aminah Jatoi et al. ONCOLOGY
- RHCG and TCAF1 promoter hypermethylation predicts biochemical recurrence in prostate cancer patients treated by radical prostatectomy
- (2016) Siri H. Strand et al. Oncotarget
- Clinical value of ERG, TFF3, and SPINK1 for molecular subtyping of prostate cancer
- (2015) Stéphane Terry et al. CANCER
- Trefoil factor 3 (TFF3) enhances the oncogenic characteristics of prostate carcinoma cells and reduces sensitivity to ionising radiation
- (2015) Omesha Perera et al. CANCER LETTERS
- The Molecular Taxonomy of Primary Prostate Cancer
- (2015) Adam Abeshouse et al. CELL
- Genomic Predictors of Outcome in Prostate Cancer
- (2015) Peter J. Boström et al. EUROPEAN UROLOGY
- PDGFB hypomethylation is a favourable prognostic biomarker in primary myelofibrosis
- (2015) Claudia Augello et al. LEUKEMIA RESEARCH
- The oncogene ERG: a key factor in prostate cancer
- (2015) P Adamo et al. ONCOGENE
- Expression profiling of prostate cancer tissue delineates genes associated with recurrence after prostatectomy
- (2015) Martin Mørck Mortensen et al. Scientific Reports
- High levels of 5-hydroxymethylcytosine (5hmC) is an adverse predictor of biochemical recurrence after prostatectomy in ERG-negative prostate cancer
- (2015) Siri H. Strand et al. Clinical Epigenetics
- ERG Cooperates with Androgen Receptor in Regulating Trefoil Factor 3 in Prostate Cancer Disease Progression
- (2015) David S. Rickman et al. NEOPLASIA
- Antibody-Based Detection of ERG Rearrangement-Positive Prostate Cancer
- (2015) Kyung Park et al. NEOPLASIA
- HTSeq--a Python framework to work with high-throughput sequencing data
- (2014) S. Anders et al. BIOINFORMATICS
- Hypermethylation of the GABRE miR-452 miR-224 Promoter in Prostate Cancer Predicts Biochemical Recurrence after Radical Prostatectomy
- (2014) H. Kristensen et al. CLINICAL CANCER RESEARCH
- Overdiagnosis and Overtreatment of Prostate Cancer
- (2014) Stacy Loeb et al. EUROPEAN UROLOGY
- Prognostic DNA Methylation Markers for Prostate Cancer
- (2014) Siri Strand et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- The value of trefoil factor 3 expression in predicting the long-term outcome and early recurrence of colorectal cancer
- (2014) KIYOTO MORITO et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Addressing overdiagnosis and overtreatment in cancer: a prescription for change
- (2014) Laura J Esserman et al. LANCET ONCOLOGY
- TFF3 and HER2 expression and their correlation with survival in gastric cancer
- (2014) Jianchun Gu et al. TUMOR BIOLOGY
- Prognostic significance of aberrantly silenced ANPEP expression in prostate cancer
- (2013) K D Sørensen et al. BRITISH JOURNAL OF CANCER
- Cancer incidence and mortality patterns in Europe: Estimates for 40 countries in 2012
- (2013) J. Ferlay et al. EUROPEAN JOURNAL OF CANCER
- Systematic Review of Complications of Prostate Biopsy
- (2013) Stacy Loeb et al. EUROPEAN UROLOGY
- V-ets erythroblastosis virus E26 oncogene homolog (avian)/Trefoil factor 3/high-molecular-weight cytokeratin triple immunostain: a novel tissue-based biomarker in prostate cancer with potential clinical application
- (2013) Kyung Park et al. HUMAN PATHOLOGY
- DNA Methylation Signatures for Prediction of Biochemical Recurrence After Radical Prostatectomy of Clinically Localized Prostate Cancer
- (2013) Christa Haldrup et al. JOURNAL OF CLINICAL ONCOLOGY
- Impact of NPM, TFF3 and TACC1 on the Prognosis of Patients with Primary Gastric Cancer
- (2013) Aiping Ding et al. PLoS One
- TFF3 Is a Normal Breast Epithelial Protein and Is Associated with Differentiated Phenotype in Early Breast Cancer but Predisposes to Invasion and Metastasis in Advanced Disease
- (2012) Ahmed R.H. Ahmed et al. AMERICAN JOURNAL OF PATHOLOGY
- Functions of DNA methylation: islands, start sites, gene bodies and beyond
- (2012) Peter A. Jones NATURE REVIEWS GENETICS
- ERG protein expression and genomic rearrangement status in primary and metastatic prostate cancer—a comparative study of two monoclonal antibodies
- (2012) M Braun et al. PROSTATE CANCER AND PROSTATIC DISEASES
- Tissue of origin determines cancer-associated CpG island promoter hypermethylation patterns
- (2012) Duncan Sproul et al. GENOME BIOLOGY
- Evaluation of GSTP1 and APC methylation as indicators for repeat biopsy in a high-risk cohort of men with negative initial prostate biopsies
- (2011) Bruce J. Trock et al. BJU INTERNATIONAL
- POTEH hypomethylation, a new epigenetic biomarker for glioma prognosis
- (2011) Xiaoping Liu et al. BRAIN RESEARCH
- Evaluation of the Infinium Methylation 450K technology
- (2011) Sarah Dedeurwaerder et al. Epigenomics
- Integrative Genomic Profiling of Human Prostate Cancer
- (2010) Barry S. Taylor et al. CANCER CELL
- Promoter hypomethylation and upregulation of trefoil factors in prostate cancer
- (2010) Else Marie Vestergaard et al. INTERNATIONAL JOURNAL OF CANCER
- Development of a Diagnostic Microarray Assay to Assess the Risk of Recurrence of Prostate Cancer Based on PITX2 DNA Methylation
- (2010) Philipp Schatz et al. JOURNAL OF MOLECULAR DIAGNOSTICS
- Multicenter Clinical Validation of PITX2 Methylation as a Prostate Specific Antigen Recurrence Predictor in Patients With Post-Radical Prostatectomy Prostate Cancer
- (2010) Lionel L. Bañez et al. JOURNAL OF UROLOGY
- TopHat: discovering splice junctions with RNA-Seq
- (2009) Cole Trapnell et al. BIOINFORMATICS
- Prostate Cancer Detected by Methylated Gene Markers in Histopathologically Cancer-Negative Tissues from Men with Subsequent Positive Biopsies
- (2009) D. A. Troyer et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- DNA Methylation of the PITX2 Gene Promoter Region is a Strong Independent Prognostic Marker of Biochemical Recurrence in Patients With Prostate Cancer After Radical Prostatectomy
- (2009) Gunter Weiss et al. JOURNAL OF UROLOGY
- Ultrafast and memory-efficient alignment of short DNA sequences to the human genome
- (2009) Ben Langmead et al. GENOME BIOLOGY
- The trefoil factor family – small peptides with multiple functionalities
- (2008) S. Kjellev CELLULAR AND MOLECULAR LIFE SCIENCES
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started